What it is: A naturally occurring copper tripeptide found in human plasma, saliva, and urine that declines significantly with age, studied for tissue regeneration and anti-aging effects.
Research suggests: Research shows GHK-Cu can activate over 4,000 genes related to tissue remodeling, anti-inflammation, and repair, with both injectable and topical forms studied.
Best for: Skin regeneration and longevity researchers
Key thing to know: Naturally present in human plasma; levels drop from roughly 200 ng/mL at age 20 to below 80 ng/mL by age 60, making it a genuine age-related decline marker.
What is GHK-Cu?
GHK-Cu (Glycyl-L-Histidyl-L-Lysine copper) is a naturally occurring tripeptide first isolated from human plasma in 1973 by Loren Pickart. It consists of the amino acid sequence Gly-His-Lys bound to a copper(II) ion , the copper is not incidental but integral to the peptide's biological activity. GHK is present in human plasma, saliva, and urine, and plasma concentrations decline significantly with age: from roughly 200 ng/mL at age 20 to below 80 ng/mL by age 60.
This age-related decline has made GHK-Cu a subject of considerable interest in longevity and regenerative medicine research.
GHK-Cu is best known in its topical form, where it is widely used in cosmetic skincare products for its effects on collagen synthesis and skin remodeling. However, the research extends well beyond cosmetic applications , Pickart's work and subsequent independent studies have identified GHK-Cu as a tissue repair signal that modulates the expression of hundreds of genes involved in inflammation resolution, antioxidant defense, DNA repair, and cellular regeneration. Systemic injectable research is less extensive than topical, but the mechanistic findings have generated substantial interest in both anti-aging and wound healing research communities.
How GHK-Cu Works
GHK-Cu's primary mechanism is as a tissue repair signal. At sites of tissue damage, GHK-Cu is released from breakdown of the larger protein albumin, acting as a local signal that activates repair and remodeling processes. The copper ion is essential , GHK without copper has significantly reduced biological activity, and copper itself without the GHK tripeptide as a carrier does not replicate GHK-Cu's effects at physiological concentrations.
The most well-characterized downstream effects involve the extracellular matrix: GHK-Cu stimulates fibroblast activity, upregulates collagen and elastin synthesis, and promotes production of glycosaminoglycans such as hyaluronic acid and chondroitin sulfate. In wound models, GHK-Cu consistently accelerates healing, reduces scar formation compared to controls, and promotes more organized tissue architecture. These effects have been observed in skin, nerve, bone, and liver tissue across independent research groups.
Loren Pickart's genomic studies identified GHK-Cu as capable of resetting the gene expression signature of aged fibroblasts toward a younger phenotype , upregulating genes associated with DNA repair, mitochondrial function, and cellular housekeeping while downregulating genes associated with inflammation and cancer progression. These broad gene expression effects, if validated in human tissue at clinically relevant doses, would represent one of the most mechanistically compelling findings in aging biology research.
What Does the Evidence Show?
Multiple controlled studies have demonstrated GHK-Cu's ability to increase skin collagen density, reduce fine lines, and improve skin elasticity when applied topically. These findings are consistent across independent research groups and align with the compound's well-characterized mechanism. Topical GHK-Cu's safety profile is well-established , it has been in cosmetic use for decades with a strong record of tolerability.
Animal and in vitro studies consistently show accelerated wound closure, improved tensile strength of healed tissue, and reduced scar formation with GHK-Cu treatment. The wound-healing evidence base is broader than for most peptides at this evidence tier, with studies across skin, nerve, bone, and gastrointestinal tissue from multiple independent research groups over several decades.
The more expansive claims around GHK-Cu , systemic longevity effects, broad gene expression reset, anti-cancer gene modulation , are primarily based on Pickart's genomic analyses using bioinformatics modeling of existing databases rather than direct experimental interventions. While mechanistically compelling, these claims have not been tested in prospective human clinical trials at systemically relevant doses.
Relevant Labs to Review
These biomarkers are most relevant to the tissue repair, inflammatory, and metabolic contexts in which GHK-Cu is studied.
Commonly Researched Alongside GHK-Cu
GHK-Cu is most often studied alongside other tissue repair and regeneration compounds, given its overlapping mechanisms in the extracellular matrix and fibroblast activation pathways.